文献速递妇科

机器人脾切除术治疗子宫内膜腺癌孤立性脾复发

Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma.
PubMed 文献 · J Minim Invasive Gynecol · 2017-11-08

本文报告一例子宫内膜癌孤立性脾实质转移的55岁患者,在初次手术及阴道残端复发后接受机器人脾切除术,手术时间90分钟、出血<50 mL,无术中及术后并发症,术后第2天出院,随访2个月无病生存。

要点

  • 子宫内膜癌孤立性脾实质转移罕见,本例采用机器人辅助脾切除术完成。
  • 手术时间90分钟、出血<50 mL,无术中及术后并发症,术后第2天出院。
  • 术后46天开始以卡铂6 AUC和多柔比星(Caelyx)30 mg/m²为基础的辅助化疗。

核心结论

  • 本病例展示了复发性子宫内膜癌的成功机器人手术治疗。

研究设计与样本

  • 病例报告(加拿大工作组分类III级),研究对象为1例55岁有子宫内膜癌病史的患者。

主要发现

  • 患者2014年行全子宫切除、双侧输卵管卵巢切除、盆腔淋巴结清扫及腹腔冲洗,最终病理为子宫内膜样腺癌,国际妇产科联盟IB期G2。
  • 初次治疗后20个月出现阴道残端复发,拒绝放疗,改行机器人手术,随后接受6周期卡铂6 AUC和紫杉醇175 mg/m²化疗。
  • 17个月后正电子发射断层扫描/计算机断层扫描发现脾脏3 cm实质内病灶,遂安排机器人脾切除术。
  • 手术时间90分钟、出血<50 mL,无术中及术后并发症,组织病理学显示脾脏3 cm实质内病灶,术后第2天出院。
  • 术后46天开始以卡铂6 AUC和多柔比星(Caelyx)30 mg/m²为基础的辅助化疗,随访2个月无病生存且一般状况良好。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To demonstrate management of a rare case of an isolated intraparenchymal splenic metastasis of endometrial cancer with robotic-assisted surgery. DESIGN: Case report (Canadian Task Force Classification III). SETTING: A 55-year-old patient with a history of endometrial cancer was found to have a splenic lesion on a follow-up examination. She underwent surgical staging, involving total hysterectomy, bilateral salpingo-oopherectomy, pelvic lymphadenectomy, and peritoneal washing, in 2014, and the final pathological findings showed an endometrioid endometrial adenocarcinoma, International Federation of Gynecology and Obstetrics stage IB G2. Multidisciplinary counseling was provided, and the patient opted for strict medical surveillance. At 20 months after the primary treatment, the patient experienced a vaginal cuff recurrence and refused radiation therapy. She instead underwent robotic surgery, followed by 6 cycles of carboplatin 6 AUC and paclitaxel 175 mg/m2. Seventeen months later, a positron emission tomography/computed tomography scan revealed a 3-cm intraparenchymal lesion of the spleen, and robotic splenectomy was scheduled. The Institutional Review Board approved this study. INTERVENTION: The operative time was 90 minutes, and blood loss was <50 mL. The operation was performed successfully, with no intraoperative and postoperative complications. Histopathological analysis showed a 3-cm intraparenchymal splenic lesion. The patient was discharged on day +2, and 46 days later started adjuvant chemotherapy based on carboplatin 6 AUC and doxorubicin (Caelyx) 30 mg/m2. At a 2-month follow-up, the patient was disease-free and in good general condition. CONCLUSION: This case demonstrates the successful robotic management of recurrent endometrial cancer.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Gallotta V, D'Indinosante M, Nero C, et al. Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma. J Minim Invasive Gynecol. 2017. PMID: 29128439. doi:10.1016/j.jmig.2017.10.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。